Product Program year 2021 Source: CMS Open Payments

Non-Covered

Open in the dashboard

General payments

$1,237,563

734 payments

Research payments

$97,137,878

28,046 payments

Through program year 2021, $1,237,563 in general payments and $97,137,878 in research payments were reported against Non-Covered.

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

6 rows
Year Kind Amount Payments
2021 General $532,413 327
2021 Research $29,574,257 5,051
2020 General $684,146 383
2020 Research $30,483,544 9,740
2019 General $21,004 24
2019 Research $37,080,077 13,255

Breakdown

Who paid General payments · program years 2019–2021
  1. Bayer HealthCare Pharmaceuticals Inc. $1,237,563 734 payments
Top recipients General payments · program year 2021
  1. Murray Epstein Hospitalist · Miami, FL $58,339 11% · 11 payments
  2. Timothy Yap Medical Oncology · Houston, TX $38,750 7% · 1 payment
  3. Rajiv Agarwal Nephrology · Indianapolis, IN $31,695 6% · 11 payments
  4. Brigham And Womens Hospital Teaching hospital · MA $17,460 3% · 2 payments
  5. Tara Chang Nephrology · Stanford, CA $12,000 2% · 8 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2021.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2021
  1. Nephrology Internal Medicine $94,191 19% · 24 practitioners
  2. Medical Oncology Internal Medicine $80,341 16% · 12 practitioners
  3. Cardiovascular Disease Internal Medicine $70,729 14% · 18 practitioners
  4. Hospitalist $58,339 12% · 1 practitioner
  5. Internal Medicine $33,909 7% · 15 practitioners

The top 5 of 36 specialties; each share is of general payments naming this product to practitioners with a specialty in 2021. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2021
  1. Texas $74,229 14% · 14 recipients
  2. Florida $69,047 13% · 10 recipients
  3. New York $60,236 11% · 14 recipients
  4. Massachusetts $48,677 9% · 11 recipients
  5. California $41,035 8% · 17 recipients

The top 5 of 31 states; each share is of general payments naming this product in 2021 where a state was reported.

The top 25 states, free in the app

734 general · 28,046 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2021

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record